Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma By Andrew Borgmann Posted July 20, 2023 In Publication Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma2023-07-202023-07-20/wp-content/uploads/2022/02/canopy-logo-2022-white.pngCanopy Biosciences/wp-content/uploads/2022/02/canopy-logo-2022-white.png200px200px 0 ChipCytometry Andrew Borgmann Recent PostsNew life science startup raises $2 million
